Journal of Medical & Surgical Pathology
Open Access

Prostate’s adenocarcinoma: How to score Gleason score, studies about cases of last three years: 2016, 2017 and 2018

Joint Event on 15^th International Conference on Surgical Pathology and Cancer Diagnosis & 4^th International Conference on General Practice & Primary Care

April 15-16, 2019 Berlin, Germany

Bouchikhaoui Hiba

Foundation Hospital University of Oran, Algeria

Scientific Tracks Abstracts: J Med Surg Pathol

Abstract :

Objective: How to score an adenocarcinoma of the prostate according to Gleason‘s score, and to grade it. Also, there is difference between the biopsy and prostatectomy in Gleason score and grade.

Methodology: In the work, author used all cases of the last three years of adenocarcinoma‘s prostate (biopsy and prostatectomy). And the work was concentrated about cases where it was difficult to differentiate between Gleason's scores requiring sometimes an immunohistochemistry, and an MCM (multidisciplinary concentrated meeting), to make a final decision and a certainty diagnosis.

Results: The diagnosis of a prostate’s adenocarcinoma is easy to appreciate, but the variant score and grade also have to be correct for the differentiation and sure for an effective therapy. The only criterion that Gleason’s score depends is the architecture.

Biography :

Bouchikhaoui Hiba is a pathologist at EHUO hospital of Oran and a 4th year resident in pathologic laboratory. She is a tutor of Histologie and Physiologic courses in Belgaid University, and INESM university & also she teaches medical English at University of biology. She is a Member of AIP (International academic of Pathologi). She published her poster in Maghrebin day in Algeria, International congress of Oncology.

E-mail: biba_s3@live.fr